Engineers Gate Manager’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-52,751
Closed -$48K 2232
2024
Q4
$48K Buy
+52,751
New +$51.8K ﹤0.01% 2090
2022
Q2
Sell
-65,655
Closed -$209K 1974
2022
Q1
$209K Sell
65,655
-6,728
-9% -$24.1K 0.01% 1605
2021
Q4
$303K Buy
+72,383
New +$406K 0.01% 1399
2020
Q4
Sell
-60,686
Closed -$484K 1744
2020
Q3
$484K Sell
60,686
-13,401
-18% -$121K 0.02% 1011
2020
Q2
$733K Buy
+74,087
New +$680K 0.04% 751
2020
Q1
Sell
-21,665
Closed -$83K 1630
2019
Q4
$83K Buy
21,665
+1,557
+8% +$6.79K ﹤0.01% 1548
2019
Q3
$101K Buy
+20,108
New +$117K 0.01% 1310

Other funds holding CTSO

Engineers Gate Manager's CTSO Position: Q1 2025 in Review

Engineers Gate Manager sold out of Cytosorbents Corp (CTSO) in Q1 2025, closing a stake of 52,751 shares — an estimated $48K sold.

Engineers Gate Manager first reported a position in CTSO in Q3 2019 and held it in 7 quarters. The position peaked at $733K in Q2 2020. 49 funds tracked by Wall St. Rank hold CTSO as of Q1 2025.

  • Engineers Gate Manager reported no remaining Cytosorbents Corp position as of Q1 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 52,751 Cytosorbents Corp shares in Q1 2025, an estimated $48K.
  • Engineers Gate Manager first reported a position in Cytosorbents Corp in Q3 2019 and held it in 7 quarters.
  • Engineers Gate Manager's Cytosorbents Corp position peaked at $733K in Q2 2020.
  • 49 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2025.

Based on Engineers Gate Manager's 13F filing for Q1 2025, filed 15 May 2025.